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KESAN KALSIUM FOSFAT DWIFASA DAN SIMVASTATIN TERHADAP  
SEL PULPA GIGI MANUSIA DALAM VITRO SEMASA REGENERASI 
DENTIN 
 
ABSTRAK  
Kajian ini adalah untuk menghasilkan perancah kalsium fosfat dwifasa (BCP)  dengan 
kombinasi simvastatin pada kepekatan optimum untuk mendorong pembezaan sel-sel 
pulpa gigi manusia dan regenerasi tisu dentin. BCP pada nisbah 20/80 hidrosiapatit 
(HA) dan β-trikalsium fosfat (β-TCP) dengan liang mikro < 10 μm, liang makro 300 
μm, dan keliangan 65% telah berjaya disintesiskan secara pemendapan basah dangan 
menggunakan mikrosfera polietilena sebagai pembentuk-liang. BCP sampel telah 
dicirikan menggunakan pembelauan sinar-x (XRD), spektroskopi jelmaan Fourier 
infra-merah (FTIR), pendarfluor sinar-x (XRF), mikroskop imbasan elektron 
(FESEM), pengecutan linear, dan kaedah Archimedes. Sampel BCP telah digabungkan 
dengan empat kepekatan simvastatin (2.0, 1.5, 1.0 dan 0.5 μM) untuk penilaian 
kebolehhidupan sel dengan menggunakan cerakin MTT (3-(4,5-dimetil-thiazonil)-2,5-
diphenil-tetrazolium bromida). Aktiviti fosfatase alkali telah diuji dengan  
menggunakan cerakin fosfatase alkali. Kumpulan yang menunjukkan kebolehhidupan 
sel  terbaik dan aktiviti fosfatase alkali telah dipilih. Kumpulan tersebut diuji bagi 
potensi  pembezaan odontogenik jenis kolagen I alfa 1 (COL1A1), sialoprotein tulang 
(BSP), matriks dentin protein-1 (DMP-1), sialofosfoprotein dentin (DSPP), dan faktor-
2 transkripsi Runt berkaitan (RUNX-2) analisis gen ekspresi menggunakan reaksi 
rantai transkripsi-polimerase berbalik (RT-PCR) dan pengesanan pemineralan matriks 
luar sel dengan menggunakan penstainan alizarin Merah S.  
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Hasil kajian menunjukkan bahawa kumpulan kombinasi BCP + 1.5 μM, BCP + 1.0 
μM, dan BCP + 0.5 μM mempunyai min indeks kebolehhidupan sel tertinggi, kecuali 
BCP+ 2.0 μM  adalah kesitotoksikan. Bagi aktiviti fosfatase alkali, kombinasi BCP + 
1.5 μM, BCP + 1.0 μM, dan BCP + 0.5 μM menunjukkan min indeks aktiviti fosfatase 
yang tinggi dengan BCP + 1.5 μM adalah tertinggi. Bagi potensi pembezaan 
odontogenik, gabungan BCP + 1.5 μM menunjukkan regulasi-menaik gen COL1A1, 
DMP-1, BSP, DSPP dan regulasi-menurun gen RUNX-2. Bagi pemineralan matriks 
sel luar, gabungan BCP + 1.5 μM menunjukkan aktiviti tertinggi untuk mengaruh 
pemendapan mineral. Sebagai kesimpulan, gabungan BCP dan 1.5 μM simvastatin 
adalah induksi terpilih untuk pembezaan sel pulpa gigi manusia terhadap regenerasi 
tisu dentin. 
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THE EFFECT OF BIPHASIC CALCIUM PHOSPHATE AND SIMVASTATIN 
ON HUMAN DENTAL PULP CELLS IN VITRO ON DENTIN 
REGENERATION 
 
ABSTRACT 
This study was conducted to prepare an appropriate biphasic calcium phosphate (BCP) 
scaffold in combination with optimal concentration of simvastatin to induce human 
dental pulp cells differentiation and dentin tissue regeneration. BCP scaffold of 20/80 
hydroxyapatite (HA) to β-tricalcium phosphate (β-TCP) ratio with micropores < 10 
µm, macropores of 300 µm, and porosity of 65 % was successfully synthesized using 
wet precipitation method and polyethylene microspheres as pore-creating agents. The 
scaffold was characterized using x-ray diffraction (XRD), fourier transform infra-red 
spectroscopy (FTIR), x-ray fluorescence (XRF), field emission scanning electron 
microscope (FESEM), linear shrinkage, and total porosity measurements. BCP sample 
extract was prepared and combined with four different concentrations of simvastatin 
(2.0, 1.5, 1.0 and 0.5 μM) for the assessment of cell viability using MTT (3-(4,5-
dimethyl-thiazoyl)-2,5-diphenyl-tetrazolium bromide) assay. The alkaline phosphatase 
activity was assessed using alkaline phosphatase assay. The groups which showed the 
best cell viability and alkaline phosphatase activity were selected.  They were assessed 
for both odontogenic differentiation potential of collagen type I alpha 1 (COL1A1), 
bone sialoprotein (BSP), dentin matrix protein-1 (DMP-1), dentin sialophosphoprotein 
(DSPP), and Runt-related transcription factor-2 (RUNX-2) genes expression analysis 
using reverse transcription-polymerase chain reaction (RT-PCR) and extracellular 
matrix mineralization detection using Alizarin Red S staining. The results showed that 
combination groups of BCP +1.5 μM, BCP + 1.0 μM, and BCP + 0.5 μM had higher 
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mean cell viability index, except BCP + 2.0 μM that showed cytotoxicity. For alkaline 
phosphatase activity, the combination groups of BCP + 1.5 μM, BCP +1.0 μM, and 
BCP + 0.5 μM showed higher mean alkaline phosphatase activity index with BCP + 
1.5 μM the highest. For the odontogenic differentiation potential, BCP + 1.5 μM 
combination group showed up-regulation of COL1A1, DMP-1, BSP, and DSPP genes 
and down-regulation of RUNX-2 gene. For the extracellular matrix mineralization, 
BCP + 1.5 μM combination group showed the highest ability to induce the mineral 
deposition. In conclusion, the combination of BCP and 1.5 μM simvastatin achieved 
together a preferable induction of human dental pulp cells differentiation toward 
dentin tissue regeneration. 
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CHAPTER ONE 
INTRODUCTION 
1.1 Background of the Study 
The tooth pulp is a unique tissue surrounded by a protective layer of dentin. The dentin 
and the pulp are related to each other embryologically, histologically, and functionally 
and are referred together as the pulp-dentin complex. The main functions of the pulp 
include formation of dentin and provide it with oxygen, nutrition, and innervations 
(Mauth et al., 2007). Pulp tissue is vulnerable to infection by external stimuli that can 
result in irreversible pulpal damage leading to loss of vitality and function in mature 
and immature tooth. Pulpless tooth becomes brittle and susceptible to cracks and 
fracture, and has no sensation to irritations making caries progression unnoticed by 
patients. In addition, the loss of pulp vitality is associated with arrested development 
of the root in immature tooth that will impact the long-term prognosis for tooth 
retention (Witherspoon, 2008). 
Vital pulp therapy is performed to preserve pulp vitality, functions, and ultimately, its 
position in the arch. It includes two well-known procedures which are pulp capping 
and pulpotomy. They are indicated for teeth that have a pulp exposure after trauma or 
caries in permanent immature or mature teeth. These procedures offer a more 
conservative approach and good alternatives to root canal therapy (Dean et al., 2010). 
Appropriate pulp capping material should be used for vital pulp therapy to promote a 
protective hard tissue formation over the pulp exposure site. For many years, calcium 
hydroxide has been considered as the gold standard material for pulp therapy; 
however, many researchers have shown that it is not the ideal material for pulp therapy 
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as it has many disadvantages (Dammaschke et al., 2010; Dean et al., 2010; Kiba et al., 
2010; Willershausen et al., 2011; Sangwan et al., 2013). 
Another pulp capping material recently developed is mineral trioxide aggregate 
(MTA) that has drawn much interest due to its beneficial effects. MTA has 
demonstrated significantly thicker, greater frequency of dentin bridge formation, and 
less porous dentin compared with calcium hydroxide. Researches have shown that 
there was no layer of necrosis and there was less pulp inflammation when MTA was 
used for pulp capping. However, many studies have demonstrated many drawbacks 
making its application limited (Bogen et al., 2008; Boutsioukis et al., 2008; Ling et 
al., 2008; Mooney and North, 2008; Parirokh and Torabinejad, 2010). 
To date, no synthetic materials can replace the functions and physiological normalcy 
of healthy tissue or can present the chemical, biological, physical characteristics and 
behaviors similar to the natural dental parts (Rosa et al., 2012). Vital pulp therapy can 
preserve pulp vitality and function but the lost tooth structure replaced by artificial 
materials does not strengthen the tooth. Regeneration of lost dental tissues can reverse 
the deteriorated tooth and reduce the risk of its fracture (Huang, 2011).  
In the early 1990s, the concept of “tissue engineering” was introduced by Langer and 
Vacanti to describe the technique for biological tissue regeneration. Tissue 
engineering can be defined as a multi-disciplinary science that brings together biology, 
engineering and clinical sciences with developing new functional healthy tissues and 
organs based on fundamental principles that involve the identification of appropriate 
cells, the development of conducive scaffolds and an understanding of the 
morphogenic signals required to induce cells to regenerate the tissues that were lost 
(Nor, 2006). 
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For dentin tissue regeneration, dental pulp tissue contains a unique type of cells known 
as dental pulp stem cells (DPSCs) that are unspecialized cells and have the ability of 
self renewal and multilineage differentiation potential in response to the appropriate 
signals (Egusa et al., 2012). These signals can be either protein or gene therapy. In 
protein therapy, bone morphogenic protein-2 (BMP-2) is considered as the most 
important growth factor that has the ability to induce the differentiation of DPSCs into 
odontoblasts. However, the delivery of a single bolus of costly growth factor that has 
short half-life is not efficient to provide the required level of proteins to target cells to 
form hard tissue (Edwards and Mason, 2006b). Gene therapy is an alternative 
approach to overcome the limitations of protein therapy that involves delivering of a 
specific growth factor gene to the target cells that replicated together with the host 
genes, and provide prolonged expression of the desired protein. The main challenge 
for gene therapy is that it does not provide a safe long-term treatment as it leads to 
significant pulp necrosis in some conditions (Fischer et al., 2011). 
Simvastatin that is widely used as a cholesterol lowering drug specifically inhibits the 
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase enzyme in 
mevalonate pathway and induces many growth factors. Besides the induction of the 
BMP-2 production, it induces transforming growth factor-beta1 (TGF-β1), vascular 
endothelial growth factor (VEGF), alkaline phosphatase enzyme, collagene-1, bone 
sialoprotein, osteocalcin, osteopontin and other factors expression in osteoblasts (Chen 
et al., 2010; Nyan et al., 2010; Zhou et al.,  2010; Zhang et al., 2011; Park, 2012; Tian 
et al., 2013) and odontoblasts (Lee et al., 2012; Karanxha et al., 2013; Varalakshmi et 
al., 2013). The distinct advantages of simvastatin for local stimulation of hard tissue 
formation are its efficient delivery to target cells, eliciting no antibody responses in 
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addition to its low manufacturing cost compared to other growth factors such as BMPs 
(Nyan et al., 2009).  
Scaffolds play a critical role in tissue engineering as temporary frameworks used to 
provide a three-dimensional microenvironment where cells can proliferate, 
differentiate and generate the desired tissue. They transport the nutrients, oxygen and 
waste products and serve as a carrier for morphogens and delivery vehicle to the target 
cells (Zhang et al., 2013). Amongst many types of materials that have been used for 
the fabrication of scaffolds, BCP of intimate mixture of more stable phase HA and 
more soluble phase β-TCP is the most appropriate material for hard tissue regeneration 
as it resembles the inorganic part of the bone and dentin. BCP achieves balance and 
gradual dissolution to release both calcium and phosphate ions in the cells 
microenvironment. Porous BCP scaffolds are considered as a conductive and inductive 
material for hard tissue regeneration (Kress et al., 2012). 
 
1.2 Problem Statement 
Vital pulp therapy can preserve pulp vitality and function but without dentin 
regeneration. Dentin regeneration is considered as a difficult task.  In spite of the 
availability of accessible source of stem cells in the pulp, these cells have the ability of 
osteogenic, adipogenic, neurogenic, chondrogenic, fibrogenic, myogenic in addition to 
dentinogenic differentiation potential. The ability to stimulate the dental pulp stem 
cells to differentiate into odontoblasts is critical in dentin regeneration. The dental 
pulp stem cells differentiation to odontoblast is mainly determined by the components 
of local microenvironment including the signals and the scaffold. Signaling molecules 
that includes both protein and gene therapies have many drawbacks that can greatly 
affect the efficiency of DPSCs differentiation into odontoblasts and subsequently 
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dentin formation. Simvastatin is a low-priced pharmacological compound that can up-
regulate more than one growth factor to stimulate cells differentiation. The successful 
use of simvastatin to promote tissue regeneration depends on its local concentration.  
The property of the scaffold’s chemical composition and structure is one of the major 
factors contributing to DPSCs morphology, proliferation, differentiation, and dentin 
tissue formation. In order to apply appropriate BCP for the induction of DPSCs 
differentiation to odontoblast, it is crucial to control the BCP chemical composition 
with specific HA/β-TCP ratios. Furthermore, the scaffolds’ structure with controlled 
porosity and pore size need to be designed and optimized to ensure its functionality. 
Currently, several synthetic routes have been utilized for the preparation of BCP 
powders and for the fabrication of porous structure scaffolds. The construction of the 
accurate scaffold with desired characteristics is intricate task and extremely 
challenging.  
To the best of our knowledge, there is a dearth of information on the synthesis of BCP 
scaffold appropriate for DPSCs differentiation for dentin tissue regeneration. In 
addition, there has been no study conducted to determine the optimal concentration of 
simvastatin to be used in combination with BCP scaffold or elucidate their effects 
together on the DPSCs proliferation, differentiation, and dentin tissue regeneration. 
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1.3 Justification of the Study 
The preparation of an appropriate extracellular microenvironment that can direct the 
DPSCs to differentiate into odontoblasts rather than other types of cell line is highly 
essential for dentin tissue regeneration. In this study, the local fabrication of highly 
pure BCP scaffold with precise HA/β-TCP ratio and convenient porous structure that 
could meet the biological needs of DPSCs differentiation to odontoblasts by using 
simple, reproducible, economic, and accurate method would be of great importance in 
the field of biomaterial synthesis. The strategy to replace the growth factor by 
simvastatin and the application of optimal concentration of simvastatin in combination 
with appropriate BCP scaffold will achieve easy, safe, efficient, cost-effective and 
more valuable approach for DPSCs differentiation and dentin tissue regeneration.  
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1.4 Objectives 
1.4.1 General Objective 
The general aim of this study is to prepare an appropriate BCP scaffold and determine 
the optimal concentration of simvastatin that can be used in combination with BCP 
scaffold to induce human dental pulp cells differentiation for dentin tissue 
regeneration. 
 
1.4.2 Specific Objectives 
1. To synthesize BCP scaffold of 20/80 HA to β-TCP ratio with micropores < 10 µm, 
macropores of 300 µm, and porosity of 65%.  
2. To characterize the synthesized BCP scaffold by XRD, FTIR, XRF, FESEM, linear 
shrinkage, and total porosity measurements. 
3. To compare the in vitro cell viability of human dental pulp cells exposed to BCP 
scaffold extract in combination with different concentrations of simvastatin using 
MTT assay. 
4. To compare the in vitro alkaline phosphatase activity of human dental pulp cells 
exposed to BCP scaffold extract in combination with different concentrations of 
simvastatin using alkaline phosphatase activity assay.  
5. To detect the in vitro odontogenic differentiation potential of COL1A1, DMP-1, 
BSP, DSPP, and RUNX-2 genes of human dental pulp cells exposed to BCP scaffold 
extract in combination with simvastatin using RT-PCR. 
6. To detect the in vitro extracellular matrix mineralization of human dental pulp cells 
exposed to BCP scaffold extract in combination with simvastatin using Alizarin Red S 
staining assay.  
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1.5 Research Hypothesis 
There is no difference among different concentrations of simvastatin used in 
combination with BCP scaffold extract in the induction of human dental pulp cells 
differentiation for dentin tissue regeneration. 
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CHAPTER TWO 
         LITERATURE REVIEW 
2.1 Tooth Development and Structures  
Tooth development is a process characterized by a series of complex reciprocal 
inductive and sequential interactions between oral epithelium and the underlying 
neural crest ectomesenchyme (Sharma et al., 2010). 
Oral epithelium provides signals for initiation of the tooth development after which the 
epithelial cells proliferate and project into the underlying neural crest ectomesenchyme 
forming the dental lamina. Initially, this projection is in a bud shape, gets pronounced 
into a cap, then bell shape forming the enamel organ that consists of two layers: outer 
layer of cells called the outer enamel epithelium (OEE) and inner layer of cells called 
the inner enamel epithelium (IEE) that differentiates into specialized cells called 
ameloblasts which lay down the enamel. The ectomesenchyme beneath the enamel 
organ condenses to form the dental papilla whose outer most layer subjacent to the 
IEE differentiates into specialized cells called odontoblasts which lay down dentin and 
the existing dental papilla matures into dental pulp (Nanci, 2007).  
The inner and outer enamel epithelium grows apically to form two cell layers called 
Hertwig’s epithelial root sheath which starts root formation and also determines the 
shape of the roots. Hertwig’s epithelial root sheath signals adjacent mesenchyme of 
the dental papilla to differentiate into odontoblasts to lay down root dentin and signals 
mesenchyme of the dental follicle which surrounds the developing tooth germ to 
differentiate into cementoblasts to form cementum, fibroblasts to form periodontal 
ligaments and osteoblasts to form alveolar bone (Ohshima, 2008) (Figure 2.1).  
 
10 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Tooth structure (http://www.webmd.com/oral-health/picture-of-the-teeth). 
 
The molecular events during this developmental process such as initiation, 
proliferation, morphogenesis, cytodifferentiation and distribution of cells are 
principally controlled and mediated by the presence of growth/morphogens factors  
such as epidermal growth factor (EGF), transforming growth factor-beta (TGF-β) 
superfamily including several members of the bone morphogenetic protein family 
(BMP-2 to BMP-7), fibroblast growth factor (FGF), wingless- and int-related proteins 
(Wnts), hedgehog proteins (Hhs), and tumor necrotic factor (TNF) families (Mitsiadis 
and Graf, 2009).  
Amongst these growth factors, BMP family seems to be the key factor in controlling 
and regulating tooth development. BMP signals are involved in communication and 
signaling between epithelium and mesenchyme during odontoblast and ameloblast 
differentiation (Nanci, 2007). 
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2.2 Pulp-Dentin Complex  
In the process of tooth development, pulp and dentin have the same embryonic origin 
and stay in a close relationship for the whole life cycle of the vital tooth maintaining 
the integrity of tooth shape and function. Any physiological or pathological reactions 
occurring at one part will affect the other. This dynamic relationship is considered to 
be “pulp-dentin complex” that makes it difficult to separate their functional behaviors 
(Mauth et al., 2007).  
2.2.1 Dental Pulp 
Dental pulp is a loose specialized connective tissue that is located in the central 
portion of the tooth and enclosed on its outer surface by dentin. It contains a variety of 
cell types, fibers, ground substance, blood and lymph vessels, and nerves. The basic 
cells of the pulp are fibroblasts which lay down fibers of the pulp. Other cells present 
in the pulp are odontoblasts, undifferentiated mesenchymal cells, blood cells, 
endothelial cells, schwann cells and cells of inflammation and immune reactions when 
present (Sharma et al., 2010). 
The pulp is divided into four layers, from the outer to the inner part: (1) the external 
layer made up of odontoblast producing dentin subadjacent to the predentin (2) The 
second layer, called “cell free zone”, poor in cells and rich in extracellular matrix 
contains capillary plexus, terminal branches of nerve fibers, and cytoplasmic processes 
of fibroblasts (3) the third layer, called “cell rich zone” contains undifferentiated 
stem/progenitor cells that display plasticity and pluripotential capabilities and serves 
as a reservoir for the replacement of destroyed odontoblasts and fibroblasts and (4) the 
inner layer comprises the collagen fibers, vascular and nervous plexus (Aquino et al., 
2008; Tziafas, 2010). 
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Anatomically, the dental pulp is almost fully encapsulated by hard dentin and the only 
connection between the dental pulp and the surrounding tissue is through the tiny root 
apexes. All of the main blood vessels and lymph drainages of dental pulp pass through 
the tooth root apexes, which make the apex the main pathway for tooth nutrition and 
waste exchange (Mauth et al., 2007). 
The primary function of the pulp is to produce dentin by odontoblasts, and maintain 
the biological and physiological vitality of dentin. The highly vascularized tissue of 
the pulp provides oxygen and nutrition to dentin, and the abundant myelinated and 
unmyelinated responsive sensory nerves function as a bio-sensor to detect unhealthy 
stimuli caused by mechanical trauma, chemical irritation or microbial invasion, and 
generate unbearable pain (Huang, 2009).  
Odontoblasts that are associated with the formation and maintenance of dentin are 
highly specialized and fully differentiated tall columnar cells of about 50 to 60 μm in 
length. These cells form a layer of cells lining the periphery of the pulp at the inner 
surface of dentin and perpendicular to the basement membrane called “pulpo-dentinal 
membrane”. This zone of attachment maintains the cells phenotype, prevents the 
entrapment of odontoblasts in the predentin matrix and ensures that the developing 
surface of dentin remains relatively flat and in one direction (Nanci, 2007). These cells 
are characterized by a unique polarized morphology with highly polarized distribution 
of cytoplasmic organelles in which a large nucleus is located in the basal portion of the 
cell, close to the pulp, while the well-defined Golgi apparatus, rough endoplastic 
reticulum, and several mitochondria are located in a dentinal direction from the 
nucleus (Tjaderhane and Haapasalo, 2009).  
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The odontoblast cell is divided into two parts (Figure 2.2), the cell body and the 
odontoblastic process. The cell body is located at the periphery of the pulp outside the 
predentin/dentin layer and involved in the synthesis of dentin extracellular matrix 
while the odontoblastic process that is a unique long unidirectional process crossing 
the predentin and extending inside dentin tubules up to the dentin-enamel junction is 
involved in the secretion of extracellular matrix molecules (MacDougall and Javed, 
2010). The extracellular matrix molecules of collagen and proteoglycans are secreted 
in the predentin, whereas other extracellular matrix molecules that are associated with 
biomineralization are secreted more distally near the mineralization front, or even 
further within the lumen of tubules (Goldberg et al., 2011).  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Mature secretory odontoblast. D = dentin; PD = predentin matrix; FO = 
fasciaoccludens; FA = fascia adherens; TW = terminal web; RER = rough 
endoplasmic reticulum; N = nucleus; Fb = fibroblast (Nanci, 2007). 
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2.2.2 Dentin 
Dentin is one of the main mineralized tissue components of the tooth that surrounds 
the pulp and is covered peripherally by enamel on the crown and by cementum on the 
root surfaces. It is a collagen-based mineralized connective tissue consisting of 
inorganic apatite crystals embedded in an extracellular matrix (Huq et al., 2005).  
Dentin formation procedure termed dentinogenesis occurs simultaneously by two 
processes: (a) the formation of a collagenous network followed by (b) precipitation of 
the inorganic mineral phase in the form of hydroxyapatite crystals in complex 
mechanisms that control the site and rate of apatite formation during the 
biomineralization process (Goldberg et al., 2011). 
2.2.2.1 Composition of Dentin 
The proportions of dentin’s components are 70% mineral phase, 20% organic phase 
and 10% water by weight and 50% mineral phase, 30% organic phase and 20% water 
by volume (Mauth et al., 2007). The dentin mineral phase includes inorganic calcium 
and phosphate that deposit as mineral crystals to mineralize the dentin organic matrix 
and form mature dentin (Luz and Mano, 2010). The dentin organic matrix consists of 
type I collagen and non-collagenous proteins. It determines dentin morphology and is 
believed to be the key in the formation of the mineral phase during the different stages 
of biomineralization process (Smith et al., 2012).  
Collagen is the dominant fibrous protein in all connective tissues including the hard 
tissues of bone, dentin, and cementum. In dentin, odontoblasts secrete a layer of 
unmineralized collagen-rich organic matrix termed predentin that lies between the 
mineralized dentin and the inner most pulpal portion. Predentin is then transformed 
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into dentin after mineral deposition. The dentin collagen fibrils are primarily type I 
collagen, with smaller amounts of type V collagen, and type III collagen. Type I 
collagen contributes up to 90% of the organic material (Orsini et al., 2007).     
Non-collagenous proteins (NCPs) are synthesized and secreted by odontoblasts that 
constituting approximately 10% of the dentin matrix (Butler et al., 2003). They are 
believed to be instrumental in mineral deposition within the extracellular dentin matrix 
as they play fundamental roles in actively promoting, controlling, and regulating 
collagen fibrillogenesis, crystal growth, and mineralization within predentin to convert 
into dentin during dentinogenesis (Qin et al., 2004). They include: 
(a) Glycoproteins 
Glycoproteins consist of two families which are small integrin-binding ligand, N-
linked glycoprotein (SIBLING) family, and secretory calcium-binding phosphoprotein 
(SCPP) family (Orsini et al., 2009). SIBLING family includes: 
(i) Dentin matrix protein-1 (DMP-1) 
DMP-1 was first isolated and characterized by George et al. in 1993. Originally, 
DMP-1 is localized in dentin along the wall of dentinal tubules and in peritubular 
dentin as well as in odontoblasts (Massa et al., 2005; Lu et al., 2007). It was proposed 
to be dentin specific protein, however its expression had also been observed in bone 
(Huang et al., 2008a). It is a multifunctional protein that regulates cell attachment, 
induces differentiation of dental pulp stem cells into odontoblasts and plays a pivotal 
role in biomineralization through a co-operative interactions between DMP-1 and type 
I collagen that initiate apatite nucleation and mineral deposition (Narayanan et al., 
2003; Ye et al., 2004; Almushayt et al., 2005; Narayanan et al., 2006).  
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It has been found that hypophosphatemia caused defective in the phosphorylation of 
DMP-1 which in turn affected their capacity to stimulate dentin development and 
mineralization (Boukpessi et al., 2006; Chaussain-Miller et al., 2007). The roles of 
DMP-1 in mineralization are supported by observations of delayed conversion of 
predentin to dentin and osteoid to bone in DMP-1- deficient mice (Peng et al., 2008). 
(ii) Dentin sialophosphoprotein (DSPP) 
DSPP is a gene discovered by MacDougall et al. in 1997. It gives rise to three proteins 
immediately cleaved after secretion into dentin sialoprotein (DSP), dentin glycoprotein 
(DGP), and dentin phosphoprotein (DPP) (MacDougall et al., 1997; Qin et al., 2003a; 
Tsuchiya et al., 2011). Originally, DSPP is expressed in odontoblasts and at a much 
lower level in bone of about 1:400 that in dentin suggesting that DSPP can be 
considered as a specific marker of odontoblasts (Qin et al., 2002). The two proteins 
DSP and DPP are abundantly and independently identified as extracellular matrix 
components of dentin (Yamakoshi et al., 2003). They play regulatory roles in the 
nucleation of hydroxyapatite onto matrix collagen and in the subsequent growth of the 
hydroxyapatite crystals (Suzuki et al., 2009). DPP is the most abundant NCPs in the 
dentin extracellular matrix discovered by Veis and Perry in 1967 as a cleavage product 
from the C-terminal side of DSPP which contains unique extended triplet amino acid 
repeat sequences (large amounts of aspartic acid and phosphoserine), forming ordered 
carboxyl-phosphate interaction ridges that is essential in the biomineralization process 
by binding calcium and presenting it to collagen fibers initiating and modulating of 
dentin hydroxyapatite formation (Prasad et al., 2010). DSP is the second most 
abundant NCPs in the dentin extracellular matrix discovered by Butler et al. in 1981 
originating from the N-terminal part of DSPP. DSP is also involved in the initiation of 
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dentin mineralization (Suzuki et al., 2009). DGP is the middle portion of DSPP 
discovered in the pig dentin extract and it has not been determined whether this 
molecule is present in other species and consequently if it has any role in the process 
of dentinogenesis (Goldberg et al., 2011).  
(iii) Bone sialoprotein (BSP) 
BSP was isolated from bovine cortical bone and subsequently characterized by Fisher 
et al. in 1983. BSP is present in mineralized tissues including bone, dentin, 
mineralizing cartilage, and cementum. Its quantity in bone is similar to that in dentin. 
BSP acts as a nucleator of the initial apatite crystals; then, as this mineral grows on the 
collagen matrix, it acts as an inhibitor in directing the growth of the crystals (Zhang et 
al., 2009a).  
(iv) Osteopontin (OPN) 
OPN is characterized by the presence of polyaspartic acid sequence and sites of 
phosphorylation that mediate hydroxyapatite binding. It has the potential to bridge 
between cells and hydroxyapatite. OPN is present in bone in relatively large quantities 
and in relatively small quantities in the matrix of reparative dentin but not in the 
matrix of physiological and reactionary dentin (Huang et al., 2008b). 
In vitro studies have shown that the polyaspartate-containing OPN is an effective 
inhibitor of apatite formation and growth (Boskey et al., 2002) while highly 
phosphorylated OPN promotes hydroxyapatite formation concluding that OPN 
phosphorylation is an important factor in the regulation of OPN-induced 
mineralization process (Gericke et al., 2005). 
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(v) Matrix extracellular phosphoglycoprotein (MEPE) 
MEPE is highly expressed in bone and dentin matrix proteins (MacDougall et al., 
2002; Trueb et al., 2007). It is associated with mineralization process. It has been 
observed that the acidic, serine and aspartate-rich MEPE is an effective mineralization 
inhibitor and the dephosphorylated MEPE has no effect on mineralization while the 
phosphorylated intact protein is an effective promoter of mineralization (Boskey et al., 
2010). MEPE is effective in promoting the differentiation of pulp cells into 
odontoblasts/osteoblast progenitors (Goldberg et al., 2011). 
SCPP family includes: 
(i) Osteocalcin (OCN) 
OCN is a vitamin K-dependent gamma-carboxylated protein. It is a small Ca-binding 
protein. It was demonstrated in dentin for the first time by Linde et al. in 1982. It is 
present in human odontoblasts and throughout the length of odontoblast processes, 
reaching the dentino–enamel junction. It has been found in smaller amounts in dentin 
than in bone (Papagerakis et al., 2002; Onishi et al., 2005). OCN binds hydroxyapatite 
controlling hydroxyapatite crystallization and affecting the growth or maturation of the 
calcium phosphate mineral phases (Goldberg et al., 2003). 
(ii) Osteonectin (ONC) 
ONC is also referred to as SPARC: Secreted Protein Acidic and Rich in Cysteine. Its 
distribution is present in unmineralized predentin for intertubular and peritubular 
dentin. ONC plays important roles in collagen fibrillogenesis and maturation, binds to 
collagen, hydroxyapatite and growth factors, regulates cell proliferation, stimulates 
angiogenesis and matrix metalloproteinases production, and modulates cell–matrix 
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interactions (Martinek et al., 2007; Delany and Hankenson, 2009). In developing 
human teeth, ONC was already expressed in the initial stages of cytodifferentiation, 
whereas OCN only appeared during the later stages (Orsini et al., 2009). 
The absence of specific molecules of DSP, DPP, DMP-1, OCN, and ONC in the pulp 
which have been identified in dentin can explain the lack of mineralization tissue in 
the pulp (Goldberg and Smith, 2004).  
(b) Dentin proteoglycans (DPGs) 
DPGs consist of two groups: small leucine-rich proteoglycans (SLRPs) family that 
includes decorin, biglycan, fibromodulin, lumican and osteoadherin, and large 
aggregating proteoglycans family that includes aggrecan, versican, neurocan, and 
brevican (Orsini et al., 2009). DPGs play structural, metabolic, and functional roles in 
soft and calcified tissues and they seem to be key components in the mineralization 
process of dentin and bone (Goldberg et al., 2005). DPGs that are present in predentin 
play important roles in matrix formation, regulate the mineralization process and 
prevent premature mineralization (Schaefer and Schaefer, 2010).  
(c) Growth factors  
Dentin contains different types of growth factors within the mineralized extracellular 
matrix that are available for release during demineralization caused by external injury 
such as caries and trauma. The diffusion of growth factors into the pulp–dentin 
complex stimulates reactionary dentinogenesis or reparative dentinogenesis (Smith et 
al., 2012). These factors include TGF-β1, insulin-like growth factor-I (IGF-I), skeletal 
growth factor/insulin-like growth factor-II (SGF/IGF-II), platelet-derived growth 
factor (PDGF), VEGF, placenta-derived growth factor (PlGF), fibroblast growth 
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factor-2 (FGF-2), and very low concentrations of epidermal growth factor (EGF) and 
adrenomedullin (ADM) (Mazzoni et al., 2012). 
(d) Serum/plasma proteins  
These proteins include albumin, transferrin, immunoglobulins (IgG, IgA and IgM) and 
Fetuin-A. It is thought that the close relationship between odontoblasts and the 
vasculature during dentinogenesis leads to the presence of these proteins within the 
dentin extracellular matrix. It is speculated that albumin is liberated only after 
demineralization of extracellular matrix while transferrin is present only during tooth 
development which is necessary for cell proliferation, morphogenesis, and 
differentiation of embryonic teeth. Then, the requirement for transferrin is lost as the 
teeth proceed from the early cap stage to the bell stage. Immunoglobulins are 
important in binding to cariogenic bacteria and facilitating their clearance by immune 
system cells. In addition, Fetuin-A prevents undesirable ectopic calcification without 
inhibiting bone or dentin mineralization (Mazzoni et al., 2012; Smith et al., 2012). 
(e) Enzymes 
Dentin demonstrates the presence of several matrix metalloproteinases (MMPs)  
enzymes that are immobilized within the intact dentin matrix, whereas these enzymes 
are released and activated when local demineralization of dentin occurs by acids 
released from cariogenic bacteria (Pashley et al., 2004). Their release is important in 
activation of growth factors and other signaling molecules incorporated within the 
dentin. The proteins encoded by DSPP gene are processed by MMP-20 and MMP-2 to 
produce the functionally active peptides (Yamakoshi, 2009). In addition, a bioactive 
peptide which promotes differentiation of dental pulp progenitor cells is generated by 
MMP-2-cleavage of DMP-1 (Chaussain et al., 2009). The other SIBLINGs and SLRPs 
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can also bind to form specific complexes for being activated (Fedarko et al., 2004). 
IGFs and TGF-β1 are modified and activated directly by enzymatic digestion (Dallas 
et al., 2002; Miyamoto et al., 2004). Recent studies have demonstrated that MMPs 
accelerate wound healing following dental pulp injury by their controlled degradation 
of the extracellular matrix which enables immune and progenitor cells to be recruited 
to the site of injury (Joo and Seomun, 2008). 
2.2.2.2 Types of Dentin 
There are three types of dentin: 
(a) Primary dentin 
It is the earliest and most prominent dentin formed during tooth development giving 
rise to the crown and root structure of the tooth (pattern of tooth organ). It lies between 
the enamel and the pulp. The most outer layer adjacent to the amelo-dentinal junction 
is known as mantle dentin. It is formed by newly differentiated odontoblasts and forms 
a layer approximately 150 μm wide. Mantle dentin is less mineralized as it lacks 
phosphoryn and has loosely packed collagen fibrils. Below mantle dentin, 
circumpulpal dentin lies that is a more mineralized dentin which makes up most of the 
dentin layer and is secreted by the odontoblasts at the rate of about 4 to 8 μm per day 
after the mantle dentin secretion before the root formation is completed (Nanci, 2007). 
(b) Secondary dentin 
Secondary dentin deposition starts immediately as the tooth becomes functional and 
the contacts between antagonistic cusps are established at slower rate of about 1 to 2 
μm per day. At this time, the tooth is still immature with incomplete root formation, 
wide open apex, and relatively thin root dentin (Figure 2.3). The root of newly erupted 
22 
 
tooth will take up to 5 years before its growth is completed (Nanci, 2007; Cameron 
and Widmer, 2008). 
                 
 
 
 
 
 
 
 
Figure 2.3: The structure of (A) mature and (B) immature tooth. The white arrow 
represents a mature closed root apex. The yellow arrow represents an immature wide 
root apex (Jamal et al., 2011).  
 
Secondary dentin deposition continues for the whole life of the tooth causing the 
decrease in the size of the pulp cavity with age as long as the pulp remains vital. It is 
characterized by a regular arrangement of dentinal tubules, usually in direct continuity 
with those of the primary dentin. Microhardness measurements indicate that secondary 
dentin is about 30% to 40% softer than primary dentin (Nanci, 2007; Goldberg et al., 
2011).  
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(c) Tertiary dentin 
Tertiary dentin is formed as a reaction to external stimuli. It is of two types: (i) 
Reactionary dentin is formed from a pre-existing odontoblast when the stimuli are 
mild or progress slowly, such as mild caries, attrition, erosion, abrasion, superficial 
fracture or restorative dentistry procedure protecting the remaining odontoblasts and 
allowing the underlying soft pulp tissue to retain its function. (ii) Reparative dentin is 
formed from newly differentiated odontoblast-like cells of a pulpal progenitor cells 
due to the death of the original odontoblasts by the effect of the stimuli that are strong 
and/or rapidly progressing, such as deep dentin caries, severe attrition, erosion, 
abrasion, deep fracture or dental operative procedure producing excessive heat. 
Tertiary dentin does not have the well-organized histological structure of dentinal 
tubules of primary or secondary dentin (Nakashima, 2005; Nanci, 2007). 
2.3 Vital Pulp Therapy 
Dental pulp tissue is vulnerable to infection by external stimuli. When infected, it is 
difficult for the immune system to eradicate the infection owing to the lake of a 
collateral blood supply except from the root apical end. The continuous stimuli can 
result in irreversible pulpal damage causing necrosis of the pulpal tissues and the pulp 
loses its vitality and function in mature and immature teeth (Witherspoon, 2008).  
The common age-group exposed to injuries is the school-aged children between 7 and 
10 years old where the permanent teeth is still immature with open apical foramen 
(>1.1 mm). Studies have shown that 25% of school-aged children have experience 
some kind of dental trauma and 25% to 65% of school-aged children have untreated 
dental caries (Garcia-Godoy and Murray, 2012). World Health Organization (WHO) 
data banks demonstrate that dental caries is still prevalent in most countries worldwide 
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(100% incidence in some populations) (Yan et al., 2011). Pulp necrosis of an 
immature permanent tooth, from the trauma or caries, arrests further root development 
and root dentin deposition leave a weak root of thin dentinal walls that is more prone 
to fracture with open apex making its restoration difficult. This leads to a poorer 
crown-to-root ratio, with possible periodontal breakdown as a result of increased 
mobility, and ultimately tooth loss (Neha et al., 2011).  
Many studies have shown that pulp vitality can be successfully protected from external 
stimuli and preserved its function by using vital pulp therapy (Flores et al., 2007; 
Sawicki et al., 2008; Witherspoon, 2008; Dean et al., 2010; Waterhouse et al., 2011). 
The primary goal of vital pulp therapy is to maintain the dental pulp vitality and 
function in mature and immature permanent teeth and to stimulate apexogenesis for 
complete root complex growth in immature teeth (Cameron and Widmer, 2008).  
Apexogenesis involves the continued normal development of the radicular root dentin 
and apical closure optimizing the root anatomy and strength that result in normal root 
thickness and length with normal apical morphology (Huang, 2008c).  
2.3.1 Types of Vital Pulp Therapy 
Clinically, there are two well-established methods for vital pulp therapy which are:  
(a) Pulp capping that includes indirect and direct pulp capping. Indirect pulp capping 
has been defined as a procedure of coarse removal of caries that retained a small 
amount of carious dentin is in deep areas of cavity preparation to avoid pulp exposure. 
A medicament is then placed over the carious dentin to produce bacteriostatic 
condition, and stimulate and encourage pulp recovery. Many studies have given a low 
prognosis to indirect pulp therapy (Pinkham et al., 2005). Direct pulp capping is a 
procedure in which a protective agent is placed directly on the pin point pulp exposure 
